注册 | 登录 | 充值

首页-> 学术资讯 -> 临床研究

CAPARES:Effects of amlodipine on ischemia after percutaneous transluminal coronary angioplasty: secondary results of the Coronary Angioplasty Amlodipine Restenosis (CAPARES) Study.

临床研究

1970-01-01      

1761 0

Am Heart J. 2003 Jun;145(6):1030-5. Jorgensen B, Thaulow E; Coronary Angioplasty Amlodipine Restenosis Study. Department of Cardiology, Rikshospitalet, University of Oslo, Oslo, Norway. bj-jorgensen@hotmail.com

BACKGROUND: Despite successful coronary angioplasty (PTCA), patients may have ischemia after the procedure because of the overall coronary disease and luminal renarrowing at the lesion sites. The aim of this study was to examine the effects of the calcium-channel blocker amlodipine on post-PTCA ischemia.

METHODS: In a prospective, double-blind design, patients were randomized to receive 10 mg of amlodipine or placebo 2 weeks before angioplasty. Exercise tests and 48-hour ambulatory electrocardiography recordings were performed in 405 patients, 2 weeks before and 2 and 20 weeks (early and late) after PTCA.

RESULTS: There were no differences in clinical and angiographic baseline characteristics between the treatment groups. Ischemia and angina were equally distributed before PTCA, and no difference in restenosis was found between the groups at follow-up. The incidence of angina was significantly lower in the amlodipine group compared with the placebo group both early and late after PTCA (P =.04 and.03). Exercise-induced ischemia was reduced by 40% (P =.009) early and 34% (P =.02) late after PTCA in the amlodipine group, and ischemia on ambulatory electrocardiography was reduced by 18% early and 28% late after PTCA compared with placebo (P =.06 and P =.009).

CONCLUSION: Ischemia and angina occurred after successful PTCA and were significantly reduced by amlodipine.



科研资讯(站内): CAPARES

百度浏览   来源 : 国际循环   


版权声明:本网站所有注明来源“医微客”的文字、图片和音视频资料,版权均属于医微客所有,非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源:”医微客”。本网所有转载文章系出于传递更多信息之目的,且明确注明来源和作者,转载仅作观点分享,版权归原作者所有。不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。 本站拥有对此声明的最终解释权。

科研搜索(百度):医学科研 CAPARES





发表评论

注册或登后即可发表评论

登录注册

全部评论(0)

没有更多评论了哦~

科研资讯 更多>>
  • 肿瘤电场治疗Optune Lua获批治疗..
  • 成本更低的实体瘤抗癌新星:CAR-..
  • 文献速递-子宫内膜癌中的卵黄囊..
  • Nature|MSCs首次用于人体跟腱病..
  • 推荐阅读 更多>>
  • SILVHIA:Comparison of actions..
  • Ohasama Study:Ambulatory Bloo..
  • Utilization of early invasive ..
  • Effects of Reviparin, a Low
    • 相关阅读
    • 热门专题
    • 推荐期刊
    • 学院课程
    • 医药卫生
      期刊级别:国家级期刊
      发行周期:暂无数据
      出版地区:其他
      影响因子:暂无数据
    • 中华肿瘤
      期刊级别:北大核心期刊
      发行周期:月刊
      出版地区:北京
      影响因子:1.90
    • 中华医学
      期刊级别:CSCD核心期刊
      发行周期:周刊
      出版地区:北京
      影响因子:0.94